XT1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - CTS Corp

Watchlist Manager

Watchlist

Price: 37.4 EUR Market Closed

Market Cap: €748.7m

C	CTS Corp XBER:XT1	US
A	Alnylam Pharmaceuticals Inc F:DUL	US
	Nexpoint Real Estate Finance Inc NYSE:NREF	US
P	Pitney Bowes Inc F:PBW	US
	Eldorado Gold Corp TSX:ELD	CA
G	Geron Corp F:GON	US
V	Vertex Pharmaceuticals Inc XMUN:VX1	US
S	Schibsted ASA XMUN:XPG	NO
F	Forte Biosciences Inc F:37TA	US
M	Moelis & Co F:17M	US
	Oculis Holding AG F:CR5	CH
	Brookfield Renewable Partners LP NYSE:BEP	BM
T	Toray Industries Inc DUS:TOR1	JP
B	Brookdale Senior Living Inc F:B7S	US
S	Sony Group Corp XMUN:SON1	JP

Profitability Summary

CTS Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

40%

Sustainable 3Y Average Gross Margin

37%

Gross Margin is Increasing

35% > 40%

Healthy Operating Margin

17%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

15% > 17%

Healthy Net Margin

12%

Sustainable 3Y Average Net Margin

11%

Net Margin is Increasing

10% > 12%

Exceptional Free Cash Flow Margin

16%

Strong 3Y Average Free Cash Flow Margin

15%

Declining Free Cash Flow Margin

18% > 16%

Positive ROE

12%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

Declining ROIC

12% > 11%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.